Individualized ANH for Non-cardiac Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorWest China Hospital
About this trial
In this trial, we proposed an individualized acute normovolemic hemodilution (ANH), and conduct a randomized controlled trial to testify the effect of individualized ANH on red cells requirement for non-cardiac surgeries with anticipating major blood loss in adults.
Eligibility criteria
Qualifiers
Patients undergoing elective non-cardiac surgery with an anticipated red blood cells transfusion >8 units (or 1600ml)
Aged 18~75 years
Preoperative Hb level > 120g/L for men and > 110g/L for women.
Disqualifiers
Refusal of blood transfusion
Cardiopulmonary insufficiency
Cerebrovascular disease
Renal impairment
Trial design
Treatments tested in this trial
- Individualized ANH
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov